ID 634 -
Kwas eikozapentaenowy
PL: Kwas eikozapentaenowy
EN: Eicosapentaenoic acid (EPA)
Pdf: eicosapentaenoic acid
Oświadczenie (2)
- wspomagające środek spokojne zachowanie i umiejętności uczenia się
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claims is eicosapentaenoic acid (EPA).
EPA is a 20-carbon fatty acid with 5 double bonds of the omega 3 series (omega-3 long-chain polyunsaturated fatty acid). It is a well recognised nutrient naturally present in foods from animal sources, especially oily fish, or used, generally in the form of triglycerides, for addition to foods or food supplements. EPA is measurable in foods by established methods.
The Panel considers that the food constituent, eicosapentaenoic acid (EPA), which is the subject of the health claims is sufficiently characterised.
2.2. Uspokojenie (ID 634)
The claimed effect is “supportive measure for a calm behaviour and for learning abilities”. The Panel assumes that the target population is the general population.
The Panel considers that calming might be a beneficial physiological effect.
2.3. Zwiększenie czujności (ID 634)
The claimed effect is “supportive measure for a calm behaviour and for learning abilities”. The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that learning abilities relate to concentration, that can be interpreted as attention, which is a well defined psychological construct and can be measured by validated tests.
The Panel considers that increased attention is a beneficial physiological effect.
3.2. Uspokojenie (ID 634)
Nineteen references have been provided to substantiate the claim. Five were reviews, 13 were human studies and one was an animal study.
The Panel notes that all the studies provided to substantiate the claimed effects of EPA reported results with mixtures of fatty acids, especially DHA and EPA, and none of them with EPA alone. The Panel considers that no conclusions can be drawn from studies on a fixed combination for the substantiation of the claim on EPA alone.
The Panel concludes that a cause and effect relationship has not been established between the consumption of EPA and calming.
3.3. Zwiększenie czujności (ID 634)
Nineteen references have been provided to substantiate the claim. Five were reviews, 13 were human studies and one was an animal study.
The Panel notes that all the studies provided to substantiate the claimed effects of EPA reported results with mixtures of fatty acids, especially DHA and EPA, and none of them with EPA alone. The Panel considers that no conclusions can be drawn from studies on a fixed combination for the substantiation of the claim on EPA alone.
The Panel concludes that a cause and effect relationship has not been established between the consumption of EPA and increased attention.
Warunki i możliwe ograniczenia stosowania oświadczenia
500 mg EPA/day
